Tang Kevin C's Form 4 filing
Aurinia Pharmaceuticals Inc. (AUPH) · filed Jun 2, 2026
- Accession no.
- 0001178579-26-000004
- Filed
- Jun 2, 2026, 9:54 PM ET
- Trade date
- May 29-Jun 2, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market purchases total $12.5M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tang Kevin CCIK 0001178579 | Director, Officer (Chief Executive Officer), 10% Owner |
| Tang Capital Management LLCCIK 0001232621 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 29, 2026 | Common Shares | PPurchaseAcquired | +2,299 | $15.35 | +$35,289.65 | 12,231,799 | Indirect | |
| May 29, 2026 | Common Shares | PPurchaseAcquired | +262,682 | $15.31 | +$4,021,661.42 | 12,494,481 | Indirect | |
| Jun 1, 2026 | Common Shares | PPurchaseAcquired | +343,521 | $15.28 | +$5,249,000.88 | 12,838,002 | Indirect | |
| Jun 1, 2026 | Common Shares | PPurchaseAcquired | +99 | $15.34 | +$1,518.66 | 12,838,101 | Indirect | |
| Jun 2, 2026 | Common Shares | PPurchaseAcquired | +206,005 | $15.28 | +$3,147,756.4 | 13,044,106 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Common Shares | JOtherAcquired | +1,000,000 | $1.65 | +$16,500 | 10,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.